Your browser doesn't support javascript.
loading
Anti-signal Recognition Particle Antibody-positive Immune-mediated Myopathy after mRNA-1273 SARS-CoV-2 Vaccination.
Tanemoto, Masanobu; Oda, Ryosuke; Toyama, Yuichiro; Shizukawa, Hirohiko; Yokokawa, Kazuki; Saito, Taro; Suzuki, Syuuichirou; Matsumura, Akihiro; Hisahara, Shin.
Afiliação
  • Tanemoto M; Department of Neurology, Sapporo Medical University School of Medicine, Japan.
  • Oda R; Department of Neurology, Sapporo Kosei General Hospital, Japan.
  • Toyama Y; Department of Neurology, Sapporo Kosei General Hospital, Japan.
  • Shizukawa H; Department of Neurology, Sapporo Kosei General Hospital, Japan.
  • Yokokawa K; Department of Neurology, Sapporo Medical University School of Medicine, Japan.
  • Saito T; Department of Neurology, Sapporo Medical University School of Medicine, Japan.
  • Suzuki S; Department of Neurology, Sapporo Medical University School of Medicine, Japan.
  • Matsumura A; Department of Neurology, Sapporo Medical University School of Medicine, Japan.
  • Hisahara S; Department of Neurology, Sapporo Medical University School of Medicine, Japan.
Intern Med ; 61(23): 3605-3609, 2022 Dec 01.
Article em En | MEDLINE | ID: mdl-36104199
ABSTRACT
A 26-year-old Japanese woman developed a fever, myalgia and gait disturbance one day after receiving the second dose of the mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. A neurological examination revealed symmetrical weakness and myalgia in proximal lower limbs, and a blood examination showed prominent elevation of creatinine kinase. Magnetic resonance imaging (MRI) revealed a high signal intensity in the thigh muscles on short-tau inversion recovery images, and antibody testing revealed positive findings for anti-signal recognition particle (SRP) antibody. Thus, anti-SRP antibody-positive immune-mediated myopathy was diagnosed. We initiated immunotherapy, and she was ultimately able to walk stably.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Doenças Musculares Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Doenças Musculares Idioma: En Ano de publicação: 2022 Tipo de documento: Article